myocilin Antibodies

Santa Cruz Biotechnology features a diverse variety of myocilin monoclonal antibodies for research applications. myocilin Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Myocilin is a protein primarily expressed in the eye, where it plays a significant role in maintaining intraocular pressure and is implicated in the pathogenesis of glaucoma. Its proper function is essential for the health of the trabecular meshwork, and mutations in the myocilin gene can lead to increased risk of developing glaucoma. Research focused on myocilin can advance understanding of ocular health and disease mechanisms. Scientists studying myocilin expression patterns can gain valuable insights into the development and progression of glaucoma. Investigating myocilin's molecular interactions helps reveal potential therapeutic targets for vision preservation. Current research directions include exploring myocilin's role in cellular signaling pathways and its impact on trabecular meshwork function. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of myocilin and its role in ocular health.